Growing Adoption of Growth Hormone Therapy, Expanding Estrogen Replacement Programs, and Government-Backed Rare Disease Initiatives Accelerate Turner Syndrome Market Growth.Austin, United States, Feb.
Molecular testing, including chromosomal microarray analysis, distinguishes between aggressive and indolent kidney cancer subtypes, aiding in accurate diagnosis. Accurate diagnosis is critical for ...
Objective: This study evaluated the utility of single nucleotide polymorphism (SNP) microarray analysis in prenatal genetic assessment of fetuses diagnosed with congenital heart disease (CHD), ...
DiGeorge Syndrome Market Outlook 2025-2035: The DiGeorge syndrome markets size is demonstrating a promising trajectory, with a projected CAGR of 4.86% across the 7 major markets between 2025 and 2035.
Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...
Thoroughbred mares Rosalind (left) and Toppy (right) at the Baker Institute for Animal Health, Cornell University. Image credit: John Enright (Cornell University, Ithaca, NY). Studies beginning around ...
Applied Biosystems™ CytoScan™ Dx and Chromosome Analysis Suite (ChAS) Dx software provide complete solution to support cytogenetic testing CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc ...
The market for microarray analysis has reached a mature phase and is on a strong growth path, driven by increasing demand for precision medicine and progress in genetic and genomic studies. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results